(PharmaNewsWire.Com, May 22, 2017 ) " Chronic Urticaria Or Hives-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Chronic Urticaria Or Hives. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chronic Urticaria Or Hives. Report also assesses the Chronic Urticaria Or Hives therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Table of Contents - Chronic Urticaria Or Hives Overview - Chronic Urticaria Or Hives Pipeline Therapeutics - Chronic Urticaria Or Hives Therapeutics under Development by Companies - Chronic Urticaria Or Hives Filed and Phase III Products - Comparative Analysis - Chronic Urticaria Or Hives Phase II Products - Comparative Analysis - Chronic Urticaria Or Hives Phase I and IND Filed Products - Comparative Analysis
- Chronic Urticaria Or Hives Discovery and Pre-Clinical Stage Products - Comparative Analysis - Drug Candidate Profiles - Chronic Urticaria Or Hives - Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - Chronic Urticaria Or Hives - Discontinued Products - Chronic Urticaria Or Hives - Dormant Products - Companies Involved in Therapeutics Development for Chronic Urticaria Or Hives
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
